This Cathie Wood's Play Just Hit A 7-Month High On A Rival's News
Stock surged to a seven-month high Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study. Freenome is…
Stay updated with breaking news from Exact Science. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stock surged to a seven-month high Tuesday after the company's colon cancer-screening rival, Freenome, unveiled the results of a pivotal study. Freenome is…
Cologuard Plus was evaluated against an independent fecal immunochemical test ,which it significantly outperformed.
Company also receives national and regional Top Workplace honors from USA Today and Wisconsin State Journal ...
Exact Sciences Corp. (NASDAQ: EXAS) shares hiked Wednesday. The company, a leading provider of cancer screening and diagnostic tests, today announced it has received the 2024 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged ...
13.03.2024 - Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, today announced online publication of the BLUE-C study results in The New England Journal of Medicine. The peer-reviewed study, 'Next-Generation ... Seite 1